2. Application Articles
  3. UCT, Inc.

Solid phase extraction of novel synthetic 2-benzyl benzimidazole opioid compounds 'nitazenes'
20 October 2023

In this application note, UCT, Inc. introduces a method to tackle the emerging threat of 2-benzyl benzimidazole opioids or 'nitazenes'. Originally developed as potential analgesics in the 1950s but never approved for medical use, these highly potent synthetic opioids are now resurfacing, posing a significant risk in the ongoing opioid epidemic. The note outlines a targeted extraction method for the analysis of nine nitazene compounds from urine and blood, utilizing UCT’s Clean Screen® DAU column and new SelectraCore® C18 core-shell column.

UCT, Inc.

Download this Article

     Page  1 Next 
Analysis of xylazine, opioids, and other common adulterants in blood and urine by SPE and LC-MS/MS20 Oct 2023
Enhanced LC-MS/MS separation of Δ⁸ and Δ⁹-THC metabolites and other cannabinoids extracted from urine samples using a polymeric SPE column20 Oct 2023
Forensic sample analysis eBook20 Oct 2023
Analysis of pesticide and mycotoxin residues in cannabis using QuEChERS extraction, ChloroFiltr dSPE cleanup and LC-MS/MS14 Sep 2023
Analysis of glyphosate, glufosinate and metabolites using UCT’s Enviro-Clean Glyphosate Push Thru Purification Cartridge27 Jun 2023
Simultaneous analysis of California cannabis pesticide residues list5 Jun 2023
Analysis of PFAS by solid-phase extraction and LC-MS/MS13 Apr 2023
In-well hydrolysis using UCT Refine Ultra-Filtration Technology15 Mar 2023
LC-MS/MS analysis of per- and polyfluoroalkyl substances6 Feb 2023

Application Article Finder